BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34585327)

  • 1. Autologous ATG-free hematopoietic stem cell transplantation for refractory autoimmune rheumatic diseases: a Latin American cohort.
    Jaime-Pérez JC; González-Treviño M; Meléndez-Flores JD; Ramos-Dávila EM; Cantú-Rodriguez OG; Gutiérrez-Aguirre CH; Galarza-Delgado DA; Gómez-Almaguer D
    Clin Rheumatol; 2022 Mar; 41(3):869-876. PubMed ID: 34585327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
    J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.
    Burt RK; Traynor AE; Pope R; Schroeder J; Cohen B; Karlin KH; Lobeck L; Goolsby C; Rowlings P; Davis FA; Stefoski D; Terry C; Keever-Taylor C; Rosen S; Vesole D; Fishman M; Brush M; Mujias S; Villa M; Burns WH
    Blood; 1998 Nov; 92(10):3505-14. PubMed ID: 9808541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?
    Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Kim CK; Lee KT; Won JH; Hong DS
    Korean J Intern Med; 2016 Jul; 31(4):750-61. PubMed ID: 27017944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.
    Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R
    Haematologica; 2010 Feb; 95(2):284-92. PubMed ID: 19773265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia.
    Konishi T; Doki N; Nagata A; Yamada Y; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Yasuda S; Yoshioka K; Inamoto K; Toya T; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Ann Hematol; 2020 Jan; 99(1):147-155. PubMed ID: 31786646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous hematopoietic stem cell transplantation in autoimmune diseases.
    Annaloro C; Onida F; Lambertenghi Deliliers G
    Expert Rev Hematol; 2009 Dec; 2(6):699-715. PubMed ID: 21082959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematopoietic stem cell transplantation for autoimmune diseases.
    Swart JF; Delemarre EM; van Wijk F; Boelens JJ; Kuball J; van Laar JM; Wulffraat NM
    Nat Rev Rheumatol; 2017 Apr; 13(4):244-256. PubMed ID: 28228650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
    Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
    Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
    Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
    Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients.
    Burt RK; Georganas C; Schroeder J; Traynor A; Stefka J; Schuening F; Graziano F; Mineishi S; Brush M; Fishman M; Welles C; Rosen S; Pope R
    Arthritis Rheum; 1999 Nov; 42(11):2281-5. PubMed ID: 10555021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stem cell treatment of autoimmune disease].
    Daikeler T; Tyndall A
    Dtsch Med Wochenschr; 2011 Aug; 136(33):1684-6. PubMed ID: 21833894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous hematopoietic stem cell transplantation for childhood autoimmune disease.
    Milanetti F; Abinun M; Voltarelli JC; Burt RK
    Pediatr Clin North Am; 2010 Feb; 57(1):239-71. PubMed ID: 20307720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma.
    Benekli M; Smiley SL; Younis T; Czuczman MS; Hernandez-Ilizaliturri F; Bambach B; Battiwalla M; Padmanabhan S; McCarthy PL; Hahn T
    Bone Marrow Transplant; 2008 Apr; 41(7):613-9. PubMed ID: 18071290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of different doses of antithymocyte globulin conditioning on immune reconstitution upon hematopoietic stem cell transplantation.
    Li Y; Wang M; Fang X; Jiang Y; Sui X; Li Y; Liu X; Wang X; Lu D; Sun X; Xu H; Wang X
    Transpl Immunol; 2021 Dec; 69():101486. PubMed ID: 34678462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.
    Bryant A; Atkins H; Pringle CE; Allan D; Anstee G; Bence-Bruckler I; Hamelin L; Hodgins M; Hopkins H; Huebsch L; McDiarmid S; Sabloff M; Sheppard D; Tay J; Bredeson C
    JAMA Neurol; 2016 Jun; 73(6):652-8. PubMed ID: 27043206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.
    Burt RK; Traynor A; Statkute L; Barr WG; Rosa R; Schroeder J; Verda L; Krosnjar N; Quigley K; Yaung K; Villa Bs M; Takahashi M; Jovanovic B; Oyama Y
    JAMA; 2006 Feb; 295(5):527-35. PubMed ID: 16449618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.
    Hawkey CJ; Allez M; Clark MM; Labopin M; Lindsay JO; Ricart E; Rogler G; Rovira M; Satsangi J; Danese S; Russell N; Gribben J; Johnson P; Larghero J; Thieblemont C; Ardizzone S; Dierickx D; Ibatici A; Littlewood T; Onida F; Schanz U; Vermeire S; Colombel JF; Jouet JP; Clark E; Saccardi R; Tyndall A; Travis S; Farge D
    JAMA; 2015 Dec; 314(23):2524-34. PubMed ID: 26670970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.
    Burt RK; Oliveira MC; Shah SJ; Moraes DA; Simoes B; Gheorghiade M; Schroeder J; Ruderman E; Farge D; Chai ZJ; Marjanovic Z; Jain S; Morgan A; Milanetti F; Han X; Jovanovic B; Helenowski IB; Voltarelli J
    Lancet; 2013 Mar; 381(9872):1116-24. PubMed ID: 23363664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.